Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.

Kristian B FilionLisa M LixOriana Hy YuSophie Dell'AnielloAntonios DourosBaiju R ShahAudray St-JeanAnat FisherEric TremblayShawn C BugdenSilvia Alessi-SeveriniPaul E RonksleyNianping HuColin R DormuthPierre ErnstSamy Suissanull null

Published in: BMJ (Clinical research ed.) (2020)

ClinicalTrials.gov NCT03939624.

Keyphrases

cardiovascular events
adverse drug
coronary artery disease
cardiovascular disease
emergency department